Hypercalcemia — Hypercalcemia occurs in up to 15 percent of patients with advanced RCC and can result from a number of different mechanisms:
●Lytic bone metastases.
●Overproduction of PTHrP [20-23]. Concurrent production of IL-6 may enhance the action of PTHrP [24,25].
●Increased production of prostaglandins that promote bone resorption [26,27]. In such patients, the hypercalcemia can respond to administration of a nonsteroidal anti-inflammatory drug (NSAID), such as indomethacin [26].